Back to Journals » Infection and Drug Resistance
Infection and Drug Resistance
ISSN: 1178-6973

Editor-in-Chief: Professor Suresh Antony
An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal, viral and parasitic) and the development and institution of preventative strategies to minimize the development and spread of resistance.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
We are currently seeking expressions of interest for an Associate Editor position on this journal
Please send your CV and a one-page vision statement detailing your overall objectives for the journal to Jade Boyd at [email protected]
Articles:
- View all (2997)
- Volume 16, 2023 (308)
- Volume 15, 2022 (735)
- Volume 14, 2021 (553)
- Volume 13, 2020 (470)
- Volume 12, 2019 (399)
- Volume 11, 2018 (262)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Latest articles:
- 5 records -
Clinical Characteristics of Enterococcus-Associated Peritonitis in Patients with Peritoneal Dialysis
Ni J, Zhou L, Wang H, Yu J, Tong M, Yu D
Infection and Drug Resistance 2023, 16:3399-3405
Published Date: 30 May 2023
Influence of Appropriate Empirical Antibiotic Treatment on the Prognosis of ICU Patients with HAP Caused by Carbapenem-Resistant Gram-Negative Bacteria
Zhang X, Jin X, Ren J, Liu J, Ma H, Fang X, Zhang H, Zhao Y, Hou Y, Luo Y, Guo L, Ma Q, Gao Y, Zhang J, Li J, Wang X, Wang G
Infection and Drug Resistance 2023, 16:3389-3398
Published Date: 30 May 2023
Genomic Epidemiology and Antimicrobial Resistance Profiles of Clostridioides difficile from Multi-Hospitals in a City in Eastern China
Shu C, Zhou J, Yu H, Fu W, Shen J, Liang L, Zheng L, Mao L, Fu X, Lv T, Chen Y
Infection and Drug Resistance 2023, 16:3379-3388
Published Date: 30 May 2023
Tuberculosis Treatment Outcome and Associated Factors Among Tuberculosis Patients Linked to Tuberculosis Treatment Clinics in Ethiopia, 2023: A Multi-Center Retrospective Study
Berhan A, Almaw A, Solomon Y, Legese B, Damtie S, Erkihun M, Alebachew Z, Eyayu T, Abeje G, Getie B
Infection and Drug Resistance 2023, 16:3367-3378
Published Date: 30 May 2023
Comparative Analysis on Clinical Characteristics Among Patients with Acute Hepatitis A Virus (HAV) and Patients with Acute Hepatitis E Virus (HEV): A Single-Center Retrospective Study from Bulgaria
Baymakova M, Kunchev M, Mihaylova-Garnizova R, Zasheva A, Plochev K, Kundurzhiev T, Tsachev I
Infection and Drug Resistance 2023, 16:3349-3366
Published Date: 29 May 2023